Prenatal screening for congenital toxoplasmosis in Campania: Preliminary report on activities and results

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 2, 2009, Pages 374-377

  Stagni, L ^a   Romano, M A ^a   Romano, A ^a   Magli, A ^a   Briganti, F ^a   del Pezzo, M A ^a   Buffolano, W ^a  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Gestational prevalence of toxoplasmosis; Prenatal screening; Prevalence of congenital toxoplasmosis

Indexed keywords

EID: 65549170732     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000200035     Document Type: Article

References (11)

1. Bagnoli F, Buffolano W, Carosi G, Cataldi G, Martinelli P 1994. Raccomandazioni per la prevenzione, diagnosi e terapia prenatale e neonatale della toxoplasmosi. Boll Soc It Med Perinat 1: 4-19.
2. Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, Ades AE 1996. Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiol Infect 116: 347-351.
3. Buffolano W, Sagliocca L, Fratta D, Tozzi A, Cardone A, Binkin N 1994. Prenatal toxoplasmosis screening in Campania region, Italy. It Gynaecol Obstet 6: 70-74.
4. EFSA Panel on Biological Hazards 2007. Surveillance and monitoring of Toxoplasma in humans, food and animals. EFSA J 583: 1-64.
5. EMSCOT - European Multicentre Study on Congenital Toxoplasmosis 2003. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 110: 112-120.
6. Gilbert RE, Peckham CS 2002. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen 9: 135-141.
7. GURI 1995. Protocolli di accesso agli esami di laboratorio e di diagnostica strumentale per le donne in stato di gravidanza ed a tutela della maternità 1995. GURI 13.4, Serie generale n° 87.
8. Lebech M, Joynson DHM, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E 1996. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 15: 799-805.
9. Leroy V, Raeber PA, Petersen E, Rachid Salmi L, Kaminski M, Villena I, Buffolano W, Gilbert RE, EUROTOXO Group 2005. National public health policies and routine programs to prevent congenital toxoplasmosis, Europe. Available from: http://eurotoxo.isped.ubordeaux2.fr/WWW_PUBLIC/DOC/EUROTOXO_R1_ P3_European_national_policies_Dec2005.pdf.
10. SYROCOT - Systematic Review on Congenital Toxoplasmosis Study Group 2007. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patient's data. Lancet 369: 115-122.
11. Thiebaut R, Leroy V, Alioum A, Binquet C, Poizat G, Salmi LR, Gras L, Salamon R, Gilbert R, Chene G 2006. Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis. Eur J Obstet Gynecol Reprod Biol 124: 3-9.